153 related articles for article (PubMed ID: 38338374)
21. Synthesis and in vitro bioactivity study of new hydrazide-hydrazones of 5-bromo-2-iodobenzoic acid.
Popiołek Ł; Patrejko P; Gawrońska-Grzywacz M; Biernasiuk A; Berecka-Rycerz A; Natorska-Chomicka D; Piątkowska-Chmiel I; Gumieniczek A; Dudka J; Wujec M
Biomed Pharmacother; 2020 Oct; 130():110526. PubMed ID: 32693180
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, β-glucuronidase inhibition and molecular docking studies of cyano-substituted bisindole hydrazone hybrids.
Abid O; Imran S; Taha M; Ismail NH; Jamil W; Kashif SM; Khan KM; Yusoff J
Mol Divers; 2021 May; 25(2):995-1009. PubMed ID: 32301032
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and preliminary screening of carbohydrazides and hydrazones of pyrrole derivatives as potential tuberculostatics.
Bijev A
Arzneimittelforschung; 2006; 56(2):96-103. PubMed ID: 16572924
[TBL] [Abstract][Full Text] [Related]
24. Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats.
Shen H; Kannari K; Yamato H; Arai A; Matsunaga M
Tohoku J Exp Med; 2003 Mar; 199(3):149-59. PubMed ID: 12703659
[TBL] [Abstract][Full Text] [Related]
25. Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.
Tayarani-Binazir KA; Jackson MJ; Strang I; Jairaj M; Rose S; Jenner P
Behav Pharmacol; 2012 Apr; 23(2):126-33. PubMed ID: 22236652
[TBL] [Abstract][Full Text] [Related]
26. Structure based discovery of novel hexokinase 2 inhibitors.
Liu Y; Li M; Zhang Y; Wu C; Yang K; Gao S; Zheng M; Li X; Li H; Chen L
Bioorg Chem; 2020 Mar; 96():103609. PubMed ID: 32007722
[TBL] [Abstract][Full Text] [Related]
27. Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans.
Polleri A; Masturzo P; Murialdo G; Carolei A
Acta Endocrinol (Copenh); 1980 Jan; 93(1):7-12. PubMed ID: 7355667
[TBL] [Abstract][Full Text] [Related]
28. Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats.
Yang X; Chen Y; Hong X; Wu N; Song L; Yuan W; Liu Z
Drug Des Devel Ther; 2012; 6():341-7. PubMed ID: 23185117
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics.
Dingemanse J; Kleinbloesem CH; Zürcher G; Wood ND; Crevoisier C
Br J Clin Pharmacol; 1997 Jul; 44(1):41-8. PubMed ID: 9241095
[TBL] [Abstract][Full Text] [Related]
30. Azapeptide Synthesis Methods for Expanding Side-Chain Diversity for Biomedical Applications.
Chingle R; Proulx C; Lubell WD
Acc Chem Res; 2017 Jul; 50(7):1541-1556. PubMed ID: 28598597
[TBL] [Abstract][Full Text] [Related]
31. One pot synthesis and biological activity evaluation of novel Schiff bases derived from 2-hydrazinyl-1,3,4-thiadiazole.
Haj Mohammad Ebrahim Tehrani K; Sardari S; Mashayekhi V; Esfahani Zadeh M; Azerang P; Kobarfard F
Chem Pharm Bull (Tokyo); 2013; 61(2):160-6. PubMed ID: 23183543
[TBL] [Abstract][Full Text] [Related]
32. Different Schiff Bases-Structure, Importance and Classification.
Raczuk E; Dmochowska B; Samaszko-Fiertek J; Madaj J
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164049
[TBL] [Abstract][Full Text] [Related]
33. Effect of L-dopa alone and with benserazide on the spontaneous activity of striatal neurones in normal and 6-hydroxydopamine-lesioned rats.
Chang WY; Webster RA
Br J Pharmacol; 1997 May; 121(2):331-7. PubMed ID: 9154345
[TBL] [Abstract][Full Text] [Related]
34. Part-II: an update of Schiff bases synthesis and applications in medicinal chemistry-a patent review (2016-2023).
Younus HA; Saleem F; Hameed A; Al-Rashida M; Al-Qawasmeh RA; El-Naggar M; Rana S; Saeed M; Khan KM
Expert Opin Ther Pat; 2023 Dec; 33(12):841-864. PubMed ID: 38115554
[TBL] [Abstract][Full Text] [Related]
35. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
36. Central action of benserazide after COMT inhibition demonstrated in vivo by PET.
Tedroff J; Hartvig P; Bjurling P; Andersson Y; Antoni G; Långström B
J Neural Transm Gen Sect; 1991; 85(1):11-7. PubMed ID: 1867835
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of substituted aromatic heterocyclic sulfonyl hydrazone compounds and in vitro anti-hepatoma activity: preliminary results.
Wei DC; Pan Y; Wang H; Xu WJ; Chen C; Zheng JH; Cai D
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4720-4729. PubMed ID: 30058713
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors.
Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM
Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863
[TBL] [Abstract][Full Text] [Related]
39. Uptake and intracellular fate of L-DOPA in a human intestinal epithelial cell line: Caco-2.
Vieira-Coelho MA; Soares-Da-Silva P
Am J Physiol; 1998 Jul; 275(1):C104-12. PubMed ID: 9688840
[TBL] [Abstract][Full Text] [Related]
40. Pituitary hormone secretion after inhibition of L-aromatic amino acid decarboxylase activity in man.
Delitala G; Devilla L; Pende A
Acta Endocrinol (Copenh); 1980 Dec; 95(4):438-43. PubMed ID: 7456974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
